This preparation is indicated for the prevention and treatment of iron, vitamin B12, and folic acid deficiencies. It is also used for the prevention of iron deficiency during pregnancy and lactation, and as prophylactic therapy to meet the recommended daily dietary allowance of iron.

Vitamin B12 (cyanocobalamin): Essential for maintaining normal erythropoiesis, nucleoprotein and myelin synthesis, cell reproduction, and normal growth. It acts as a coenzyme in metabolic processes including protein synthesis and carbohydrate metabolism. It also plays an important role in cell replication and hematopoiesis.

Iron: An essential component for hemoglobin formation. Adequate iron levels are necessary for effective erythropoiesis. Iron also functions as a cofactor for several important enzymes, including cytochromes involved in electron transport. It replenishes iron stores found in hemoglobin, myoglobin, and enzymes, and assists in oxygen transport through hemoglobin.

Folic acid: Necessary for nucleoprotein synthesis and maintenance of normal erythropoiesis. Folic acid is converted in the liver and plasma into its metabolically active form, tetrahydrofolic acid, by dihydrofolate reductase. It helps prevent neural tube defects in women of childbearing age, and increased doses may be required during pregnancy.

Adult: 1-2 capsules daily; as recommended by the physician.
Children: 1 capsule daily; as recommended by the physician.
Infant: As recommended by the physician.

No significant drug interactions have generally been reported. Iron may reduce the absorption of antacids, tetracycline, quinolone antibiotics, levodopa, levothyroxine, methyldopa, and penicillamine. Folic acid may interact with antiepileptic medications, and plasma concentrations of phenobarbital and phenytoin may possibly be reduced.

This preparation is contraindicated in patients with known hypersensitivity to any of its ingredients.

This preparation is generally well tolerated. However, in some individuals, oral iron preparations may cause side effects such as nausea, vomiting, constipation, or diarrhea.

This preparation may be used during pregnancy and lactation.

Caution should be exercised in conditions associated with the risk of iron overload, such as haemochromatosis, thalassaemia, haemosiderosis, or haemolytic anaemia.

In cases of overdose, symptoms such as epigastric pain, diarrhea, and vomiting may initially occur. Metabolic acidosis, convulsions, and coma may develop later. In overdose situations, an emetic should be administered followed by gastric lavage and supportive treatment measures.

Iron & Vitamin Combined preparations

Store in a cool and dry place. Protect from light.